Literature DB >> 7397944

Antitumor drug toxicity in tumor-free and tumor-bearing mice.

S D Harrison, H D Giles, E P Denine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397944     DOI: 10.1007/bf00254019

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  16 in total

1.  Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials.

Authors:  J S Penta; M Rozencweig; A M Guarino; F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.

Authors:  J A Houghton; P J Houghton; R S Wooten
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

3.  Effects in vivo of lymphoma ascites tumors and procarbazine, alone and in combination, upon hepatic drug- metabolizing enzymes of mice.

Authors:  D J Reed
Journal:  Biochem Pharmacol       Date:  1976-01-15       Impact factor: 5.858

4.  Changes in polyamine levels and protein synthesis rate during rat liver carcinogenesis induced by 4-dimethylaminoazobenzene.

Authors:  A Perin; A Sessa
Journal:  Cancer Res       Date:  1978-01       Impact factor: 12.701

5.  Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.

Authors:  E P Denine; S D Harrison; J C Peckham
Journal:  Cancer Treat Rep       Date:  1977 May-Jun

6.  Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology.

Authors:  D J Prieur; D M Young; R D Davis; D A Cooney; E R Homan; R L Dixon; A M Guarino
Journal:  Cancer Chemother Rep 3       Date:  1973-01

7.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

8.  A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model.

Authors:  K Lundholm; S Edström; L Ekman; I Karlberg; A C Bylund; T Scherstén
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

9.  Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.

Authors:  T H Corbett; D P Griswold; B J Roberts; J C Peckham; F M Schabel
Journal:  Cancer Treat Rep       Date:  1978-10

10.  Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.

Authors:  T L Pazdernik; E M Uyeki
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

View more
  7 in total

1.  Inhibitory effects of calmodulin antagonists on urinary enzyme excretion in rats after nephrotoxic doses of mercuric chloride.

Authors:  S D Harrison; J L Cox; R C Giles
Journal:  Bull Environ Contam Toxicol       Date:  1985-03       Impact factor: 2.151

2.  Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.

Authors:  P E Noker; L Simpson-Herren; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.

Authors:  M J Yagi; M Zanjani; J F Holland; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  An investigation of the mouse as a model for vincristine toxicity.

Authors:  S D Harrison
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity.

Authors:  L Simpson-Herren; P E Noker; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Effects of prochlorperazine on experimental nephrotoxicity.

Authors:  S D Harrison; J L Cox; R C Giles
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

7.  Alterations in plasma pharmacokinetics of cisplatin in tumor-bearing rats.

Authors:  C L Litterst; R Magin
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.